Johannes-Paul Fladerer-Grollitsch

Dr. Johannes-Paul Fladerer-Grollitsch

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2024 in Bone Reports
Verified
Journal Article
Open access
JFJohannes-Paul Fladerer-Grollitsch
Johannes-Paul Fladerer-Grollitsch
SGSelina Grollitsch
Selina Grollitsch
Bone loss is a well-known phenomenon in the older population leading to increased bone fracture risk, morbidity, and mortality. Supplementation of eggshell membrane (ESM) is evaluated due to its possible application to prevent bone loss and usage in osteoporosis therapy. The similar organic chemical composition of ESM and human bone is described in detail as both mainly consist of collagen type I, chondroitin sulfate, dermatan sulfate, hyaluronic acid and elastan. ESM and its components are reported to improve mineralization in bone tissue. In many studies ESM intake reduced pain in patients with joint disorders and reduced inflammatory processes. Additionally, ESM improved calcium uptake in human cells. These findings in comparison with a clinical pilot study reporting pain reduction in osteoporotic patients and increased osteoblast activity in in vitro assays support ESM to be a beneficial supplement for bone health. In this systematic review we combined chemical structure analysis with clinical studies to give a more comprehensive picture with novel explanations.

30 August 2021 in Plants
Verified
Journal Article
Open access
PDF file
FAFabian Alperth
Fabian Alperth
LMLena Melinz
Lena Melinz
JFJohannes-Paul Fladerer-Grollitsch
Johannes-Paul Fladerer-Grollitsch
Franz BucarFranz Bucar
Franz Bucar
Reynoutria japonica Houtt. is a critical invasive alien plant in Europe and North America with a drastic impact on native flora. However, R. japonica has medicinal potential, especially as a source of stilbenes. In order to explore the potential of simple extractions of R. japonica, we conducted qualitative and quantitative analyses of fresh R. japonica rhizome infusion, decoction, and macerates with ethanol by UHPLC-DAD-ESI-MSn and UHPLC-DAD, with a focus on major constituent groups of stilbenes and anthranoids. Since R. japonica rhizome extracts showed antimicrobial potential in the past, we also evaluated the antimycobacterial effect of raw R. japonica extracts for the first time against Mycobacterium smegmatis. Of thirty-four characterized substances, six were stilbenes and twelve anthranoids. The main constituents, four trans-stilbenes and eight anthranoids, were quantified in a validated UHPLC-DAD method. The 38% ethanol macerate showed high stilbene (155.078 mg/100 g fluid extract) and low anthranoid content (5.420 mg/100 g fluid extract), while decoction showed the highest anthranoids. Antimycobacterial testing gave good results for all macerates (MIC 256 µg/mL) and trans-resveratrol (64 µg/mL). Extraction and enrichment of stilbenes from fresh plant material by simple extraction methods with food-grade solvents might encourage consideration of wild harvest of rhizomes over classic means of eradication of R. japonica.

16 November 2023 in Current Cardiology Reports
Verified
Journal Article
Open access
PDF file
JFJohannes-Paul Fladerer-Grollitsch
Johannes-Paul Fladerer-Grollitsch
SGSelina Grollitsch
Selina Grollitsch
Purpose of Review: According to the World Health Organization (WHO), cardiovascular disease is the leading cause of death worldwide. Heart failure has been defined as a global pandemic leading to millions of deaths. Recent research clearly approved the beneficial effect of Coenzyme Q10 supplementation in treatment and prevention of cardiovascular disease in patients with heart failure in clinical trials but did not distinguish between the oxidised form CoQ10 and reduced form CoQH2 of Coenzyme Q10. The aim of this study is to determine differences in medical application of CoQ10 and CoQH2 supplementation and evaluate the efficacy of CoQ10 and CoQH2 supplementation to prevent cardiovascular disease in patients with heart failure. Recent Findings: A PubMed search for the terms “ubiquinone” and “ubiquinol” was conducted, and 28 clinical trials were included. Our findings go along with the biochemical description of CoQ10 and CoQH2, recording cardiovascular benefits for CoQ10 and antioxidative and anti-inflammatory properties for CoQH2. Our main outcomes are the following: (I) CoQ10 supplementation reduced cardiovascular death in patients with heart failure. This is not reported for CoQH2. (II) Test concentrations leading to cardiovascular benefits are much lower in CoQ10 studies than in CoQH2 studies. (III) Positive long-term effects reducing cardiovascular mortality are only observed in CoQ10 studies. Summary: Based on the existing literature, the authors recommend CoQ10 instead of CoQH2 to treat and prevent cardiovascular disease in patients with heart failure.

15 July 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JFJohannes-Paul Fladerer-Grollitsch
Johannes-Paul Fladerer-Grollitsch
TKThomas Klein
Thomas Klein
AKAlbert Kompek
Albert Kompek
NSNicole Steiner
Nicole Steiner
DMDaniel Menzel
Daniel Menzel
CSChristiane Schön
Christiane Schön
Osteoarthritis (OA) is a prevalent degenerative joint disease, often affecting the elderly, characterized by cartilage degradation and bone remodelling, leading to pain, stiffness, and impaired movement. This 12-week, randomized, double-blind, placebo-controlled pilot study investigated the efficacy of a formulation containing collagen type II, glucosamine hydrochloride and chondroitin sulfate, in alleviating knee OA symptoms in subjects with mild to moderate knee pain. Fifty-four participants were enrolled, with 52 completing the study. Participants were assessed using the Knee injury and Osteoarthritis Outcome Score (KOOS), performance-based physical function tests and global assessment tests. Results indicated significant improvements in the verum group compared to placebo. KOOS subscales showed improvements in symptoms (8.16%, p < 0.05), sport/recreation (25.25%, p < 0.01), and quality of life (27.66%, p < 0.001). Stiffness improved by 14.68% (p < 0.05) in the verum group. Both groups exhibited significant pain reduction (KOOS pain, p < 0.001 and p < 0.01 for verum and placebo, respectively). Performance-based measures, such as the Chair Stand test, improved significantly in both groups, though other metrics showed no significant differences. The verum group exhibited a linear improvement over 12 weeks, contrasting with the placebo group’s initial response and subsequent plateau. SF-36 Physical Component scores improved in both groups (p < 0.05), but mental health scores remained unchanged. Global assessment favoured the verum group, with more participants reporting OA improvement and recommending the product (p < 0.01). Biomarkers hsCRP and COMP showed no significant changes, likely due to sample variability. While the study did not achieve its primary endpoint, the nutritional formulation demonstrated an excellent safety profile and encouraging improvements in patient-reported symptoms and quality of life, warranting larger confirmatory trials. Registration number: DRKS00029563 05/10/2022

30 July 2023 in Archives of Insect Biochemistry and Physiology
Verified
Journal Article
Open access
JFJohannes-Paul Fladerer-Grollitsch
Johannes-Paul Fladerer-Grollitsch
SGSelina Grollitsch
Selina Grollitsch
FBFranz Bucar
Franz Bucar
Cuticular hydrocarbons (CHCs) play various roles in insects' chemical ecology. As leafcutter ants live in a specific symbiosis with fungi, they harvest and with different bacteria, some of these CHCs might be associated with a mutualistic function within this symbiosis. To obtain a more precise picture in that respect we compared the CHC profiles of the leafcutter ants, Atta sexdens, Atta cephalotes, and Acromyrmex octospinosus inhabited by mutualistic bacteria with the profiles of Polyrhachis dives and Messor aciculatus by GC‐EI‐MS analysis and 28 other ant species by data from the literature. We were able to identify three alkyl amides (hexadecanamide, hexadecenamide, and tetradecanamide), occurring only in the CHC profiles of leafcutter ants inhabited by symbiotic bacteria. Our results lead to the conclusion that those alkyl amides could have a function in the tripartite symbiosis of leafcutter ants.

26 August 2023 in Phytochemistry Letters
Verified
Journal Article
Closed access
JFJohannes-Paul Fladerer-Grollitsch
Johannes-Paul Fladerer-Grollitsch
SGSelina Grollitsch
Selina Grollitsch
FBFranz Bucar
Franz Bucar